Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

Benzer Materyaller

• Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012–2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial
  Yazar:: Langley, Joanne M., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine
  Yazar:: Jain, Varsha K, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
  Yazar:: Langley, Joanne M., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6–35 Months of Age During 2013–2014: Results From A Phase II Randomized Trial
  Yazar:: Wang, Long, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10–25 Years of Age
  Yazar:: Halperin, Scott A., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)